Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib

NCT03094052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Breast Adenocarcinoma
Stage II Breast Cancer AJCC v6 and v7
Stage IIA Breast Cancer AJCC v6 and v7
Stage IIB Breast Cancer AJCC v6 and v7
Stage III Breast Cancer AJCC v7
Stage IIIA Breast Cancer AJCC v7
Stage IIIB Breast Cancer AJCC v7
Stage IIIC Breast Cancer AJCC v7

Interventions

DRUG: Neratinib
BIOLOGICAL: Trastuzumab
DRUG: Loperamide
DRUG: Crofelemer
DRUG: Diphenoxylate/Atropine

Sponsor

University of California, San Francisco

Collaborators

[object Object]